Arvinas, Inc. (ARVN)
NASDAQ: ARVN · IEX Real-Time Price · USD
32.54
-1.46 (-4.29%)
At close: Apr 24, 2024, 4:00 PM
32.49
-0.05 (-0.15%)
After-hours: Apr 24, 2024, 6:20 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $2.22 billion as of April 24, 2024. Its market cap has increased by 48.22% in one year.
Market Cap
2.22B
Enterprise Value
959.46M
1-Year Change
48.22%
Ranking
Category
Stock Price
$32.54
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $500.50M to $2.22B, an increase of 344.11%. That is a compound annual growth rate of 30.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2024 | 2.31B | -2.58% |
| Apr 22, 2024 | 2.38B | 0.52% |
| Apr 19, 2024 | 2.36B | 1.26% |
| Apr 18, 2024 | 2.33B | 2.51% |
| Apr 17, 2024 | 2.28B | 0.03% |
| Apr 16, 2024 | 2.28B | -3.69% |
| Apr 15, 2024 | 2.36B | -4.33% |
| Apr 12, 2024 | 2.47B | -2.60% |
| Apr 11, 2024 | 2.54B | 1.44% |
| Apr 10, 2024 | 2.50B | -3.54% |
| Apr 9, 2024 | 2.59B | 1.14% |
| Apr 8, 2024 | 2.56B | 0.56% |
| Apr 5, 2024 | 2.55B | -1.21% |
| Apr 4, 2024 | 2.58B | -1.79% |
| Apr 3, 2024 | 2.63B | -1.15% |
| Apr 2, 2024 | 2.66B | -3.37% |
| Apr 1, 2024 | 2.75B | -2.13% |
| Mar 28, 2024 | 2.81B | -0.12% |
| Mar 27, 2024 | 2.81B | 0.81% |
| Mar 26, 2024 | 2.79B | 0.81% |
| Mar 25, 2024 | 2.77B | -2.93% |
| Mar 22, 2024 | 2.85B | -3.34% |
| Mar 21, 2024 | 2.95B | -1.84% |
| Mar 20, 2024 | 3.01B | 3.76% |
| Mar 19, 2024 | 2.90B | -0.09% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICU Medical | 2.36B |
| STAAR Surgical Company | 2.35B |
| Patterson Companies | 2.33B |
| Teladoc Health | 2.33B |
| LifeStance Health Group | 2.33B |
| Integra LifeSciences Holdings | 2.30B |
| Denali Therapeutics | 2.30B |
| Tandem Diabetes Care | 2.26B |